GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults (Q66033114)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults |
clinical trial |
Statements
A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment of Suspected or Confirmed Gram-negative Severe Sepsis in Adults (English)
0 references
1 September 2004
0 references
1 April 2007
0 references
1,415
0 references
18 year
0 references